General Science20 Concepts & Facts

Bacteriophages: Lytic vs Lysogenic Cycles & Phage Therapeutics

Reviewed by the Master10 Editorial Board for accuracy, clarity and competitive-exam relevance.Editorial Policy

A bacteriophage, commonly abbreviated as phage, is a specialized virus that infects, replicates within, and destroys bacterial hosts and archaea. Independently discovered by English microbiologist Frederick Twort in 1915 and French-Canadian microbiologist Félix d'Hérelle in 1917, bacteriophages represent the most abundant biological entities in the biosphere, with an estimated global population exceeding ten to the thirty-first power particles. Classified under diverse taxonomic orders within the realm Duplodnaviria and Caudoviricetes, most characterized phages exhibit tailed icosahedral morphologies, containing double-stranded deoxyribonucleic acid encapsidated within a proteinaceous capsid attached to an contractile or non-contractile tail structure designed for host cell wall penetration.

The viral life cycle proceeds primarily through two alternative pathways: the virulent lytic cycle and the temperate lysogenic cycle. Infection initiates when phage tail fibers recognize specific outer membrane proteins, lipopolysaccharides, or teichoic acids on the bacterial surface, triggering conformational contraction that injects the viral genetic material into the bacterial cytoplasm. In the lytic pathway, exemplified by T4 phage, viral genes commandeer host transcription and translation machinery, synthesize early enzymes that degrade bacterial chromosomal DNA, replicate phage genomes, and assemble progeny virions before deploying endolysins and holins to lyse the bacterial wall. Conversely, in the lysogenic pathway, exemplified by lambda phage, the viral genome integrates stably into the host chromosome as a latent prophage, governed by the CI repressor protein until environmental stress activates RecA-mediated cleavage, inducing lytic reactivation.

Bacteriophages have driven historical milestones across molecular biology, serving as model organisms in the 1952 Hershey-Chase experiment confirming DNA as genetic material and inspiring bacterial defense discoveries such as restriction endonucleases and CRISPR-Cas immune systems. With escalating global antimicrobial resistance, phage therapy has experienced a clinical renaissance as a targeted precision antimicrobial capable of eradicating multidrug-resistant bacterial pathogens without disturbing beneficial commensal microflora. In competitive examinations and life sciences, questions frequently evaluate structural phage components, the genetic switch regulating lambda lysogeny, transduction mechanisms facilitating horizontal gene transfer, and biotechnological applications such as phage display and food biopreservation.

Key Concepts & Self-Assessment20 Key Facts

Review key Bacteriophages: Lytic vs Lysogenic Cycles & Phage Therapy exam facts and rate your mastery to track revision.

Progress: 0/20 Rated 0 Mastered 0 Review Later

Bacteriophages, or phages, are viruses that specifically infect and replicate within bacteria and archaea.

English bacteriologist Frederick Twort discovered bacteriophages in 1915, and French-Canadian scientist Félix d'Hérelle independently isolated and named them in 1917.

Bacteriophages are the most abundant biological entities on Earth, with an estimated global census of approximately 10 to the 31st power particles.

Tailed bacteriophages belonging to the class Caudoviricetes comprise the vast majority of identified phages, displaying double-stranded DNA genomes.

A typical tailed phage features a proteinaceous icosahedral capsid head containing the viral genome, attached to a tail structure equipped with baseplates and fibers.

Infection initiates when phage tail fibers recognize and bind specific receptor targets on the host bacterial cell wall, such as lipopolysaccharides or porins.

Upon receptor binding, conformational contraction of the tail sheath acts like a hypodermic needle, injecting the phage genome across the bacterial cell envelope.

In the virulent lytic cycle, the phage genome takes control of host cellular machinery to rapidly produce viral structural proteins and replicate genomic DNA.

Phage-encoded holin proteins assemble pores in the bacterial inner membrane, enabling endolysins to cross into the periplasm and digest cell wall peptidoglycan.

#10

Phage burst size refers to the average number of viable infectious virions released per lysed bacterial cell, typically ranging from 50 to hundreds.

#11

In the temperate lysogenic cycle, the phage genome integrates into the host bacterial chromosome as a dormant prophage without killing the host cell.

#12

The lambda phage genetic switch between lysis and lysogeny is controlled by competing repressor proteins, specifically CI repressor and Cro activator.

#13

Lysogenic conversion occurs when a prophage imparts new phenotypic traits to its bacterial host, including toxin production in Corynebacterium diphtheriae and Vibrio cholerae.

#14

Prophage induction occurs when DNA damage activates bacterial RecA, prompting autocatalytic cleavage of the CI repressor and initiating lytic viral replication.

#15

In 1952, Alfred Hershey and Martha Chase used radioactive phosphorus-32 and sulfur-35 labeling in T2 phage to prove that DNA is the genetic material.

#16

Bacteriophages mediate generalized and specialized transduction, facilitating horizontal gene transfer and spreading genetic adaptations across bacterial populations.

#17

Bacteria evolved multiple antiviral defense mechanisms against phages, including restriction-modification systems, abortive infection, and adaptive CRISPR-Cas immunity.

#18

Phage therapy utilizes targeted lytic bacteriophages as biological therapeutics to treat multidrug-resistant bacterial infections, pioneering personalized antimicrobial medicine.

#19

Phage therapy offers high host specificity, killing pathogenic target strains without disrupting beneficial commensal human microbiome ecosystems.

#20

Phage display technology, developed by George Smith in 1985, couples phage coat proteins to foreign peptides, winning the 2018 Nobel Prize in Chemistry.

Subject Specialist Commentary

Analytical perspective & practical exam advice from the Master10 academic board

Educator's Insight

Bacteriophages are nature's most efficient microscopic hunters, functioning as viruses calibrated solely to destroy bacteria. Resembling lunar landing modules under electron microscopy, phages land on bacterial walls, inject their genetic instructions, and either hijack the cell to produce hundreds of copies or hide quietly inside the bacterial chromosome. Because they never attack human cells, phages offer an effective weapon against antibiotic-resistant bacteria.

In competitive exams, examiners test the contrast between lytic and lysogenic cycles, alongside landmark experiments like Hershey-Chase. Be alert to traps: phages possess zero intrinsic metabolism and cannot replicate without a living bacterial host. Also note that prophages often confer deadly bacterial virulence, as seen in cholera and diphtheria toxins. Use the mnemonic 'Lytic Lysing, Lysogenic Lurking' to distinguish immediate destruction from stealthy prophage integration.

Bacteriophages: Lytic vs Lysogenic Cycles & Phage Therapeutics

Key Concepts & Self-Assessment20 Key Facts

Subject Specialist Commentary

Related Knowledge Topics to Discover

Looking for more GK practice?